HOME
• effexor pharmaceutical
• generic of effexor
• effexor withdrawel violence
• reducing effexor

effexor versus paxil

Although these events occurred during treatment with venlafaxine, causality has not been determined. A case of dose-related increase of intraocular pressure caused by venlafaxine use effexor versus paxil been reported. Metabolic Metabolic side effects have included weight loss (3%). Metabolic side effects reported in premarketing Phase 3 trials have included weight gain, increased alkaline phosphatase, dehydration, hypercholesteremia, hyperglycemia, hyperlipemia, hypoglycemia, effexor versus paxil increased SGOT (AST), increased SGPT (ALT), thirst, bilirubinemia, increased BUN, increased creatinine, diabetes mellitus, glycosuria, gout, abnormal healing, hemochromatosis, hypercalcinuria, hyperkalemia, hyperphosphatemia, hyperuricemia, hypocholesteremia, hyponatremia, hypophosphatemia, hypoproteinemia, and uremia. In a flexible-dose study, with doses in the range of 200 to 375 mg/day and mean dose greater than 300 mg/day, the mean change in heart rate was 8.5 beats per minute compared with 1.7 beats per minute for placebo. Other Events Observed During the Premarketing Evaluation of Venlafaxine During its premarketing assessment, multiple doses of Effexor were administered to 2897 patients in Phase 2 and Phase 3 studies. In premarketing trials, treatment with Effexor tablets was associated with a mean final on-therapy increase in total cholesterol of 3 mg/dL. Patients treated with Effexor tablets for at least 3 months in placebo-controlled 12-month extension trials had a mean final on-therapy increase in total cholesterol of 9.1 mg/dL compared with a decrease of 7.1 mg/dL among placebo-treated patients. These antidepressants have marked dose-dependent effects on rapid eye movement (REM) sleep, causing reductions in the overall amount of REM sleep over the night and delays the first entry into effexor versus paxil sleep (increased REM sleep onset latency (ROL)), both in healthy subjects and depressed patients. However, there is a dose dependency for blood pressure increase. Laboratory Changes Of the serum chemistry and hematology parameters monitored during clinical trials with Effexor, a statistically significant difference with placebo was seen only for serum cholesterol. Although these events occurred during treatment with venlafaxine, causality has not been determined. There have been a minimum of approximately fifteen cases of hyponatremia in which at least one was life threatening, including at least one case of recurrent venlafaxine- induced hyponatremia after rechallenge. A recent short-term study (6 weeks) has reported an average weight loss of 2 to 3 pounds in patients treated with venlafaxine. Numerous cases of hyponatremia have been reported following treatment with a selective serotonin reuptake inhibitor (SSRI). In effexor versus paxil effexor versus paxil premarketing assessment of Effexor XR (the extended release form of venlafaxine), multiple doses were administered to 705 patients in Phase 3 major depressive disorder studies and Effexor was administered to 96 patients.

Go To...

• effexor free trial
• taking wellbutrin and effexor together
• 75 effexor xr
• effexor and hoodia
• effexor for social anxiety

effexor versus paxil

Try to take venlafaxine at the same time each day. In addition, at least 7 days should be allowed after stopping Effexor before starting an MAOI (see CONTRAINDICATIONS). Effexor is not indicated for weight loss alone or in combination with other products. In outpatient settings there was no evidence of usefulness of doses greater effexor versus paxil 225 mg/day for moderately depressed patients, but more severely depressed inpatients responded to a effexor versus paxil dose of 350 mg/day. Overall, approximately 2/3 of all patients in these trials were women. The clinical significance of elevated 2-OH-desipramine levels is unknown. Ask your health care provider any questions you may have about how to use Effexor. The degree of binding of venlafaxine to human plasma is 27% ± 2% at concentrations ranging from 2.5 to 2215 ng/mL. Prescriptions for Effexor should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose. The frequencies presented, effexor versus paxil represent the proportion of effexor versus paxil 5356 patients exposed to multiple doses of effexor versus paxil formulation effexor versus paxil venlafaxine who experienced an event of the type cited on at least one occasion while receiving venlafaxine. Food and Drug Administration for all antidepressants. In hepatically impaired subjects, ODV oral elimination half-life was prolonged by about 40%, while oral clearance for ODV was similar to that for normal subjects. Do not take venlafaxine together with desvenlafaxine (Pristiq). You may have thoughts about suicide when you first start taking an antidepressant, especially if you are younger than 24 years old. You should consult your doctor before combining Effexor with other drugs effexor versus paxil affect the central nervous system, including lithium, migraine medications known as triptans, narcotic painkillers, sleep aids, weight-loss products such as phentermine, tranquilizers, antipsychotic medicines, and other antidepressants that affect serotonin, such as fluoxetine and paroxetine. The patient who ingested 2.75 g of venlafaxine was observed to have 2 generalized convulsions and a prolongation of QTc to 500 msec, compared with 405 msec at baseline. Drug information contained herein may be time sensitive. Mutagenicity Venlafaxine and the major human metabolite, O-desmethylvenlafaxine (ODV), were not mutagenic in the Ames reverse mutation assay in Salmonella bacteria or the CHO/HGPRT mammalian cell effexor versus paxil gene effexor versus paxil assay. Antidepressant medicines have other side effects. In a flexible-dose study, with doses in the range of 200 to 375 mg/day and mean dose greater than 300 mg/day, the mean pulse was increased by about 2 beats per minute compared with a decrease of about 1 beat per minute for placebo.